← All news
Markets
Has Solvonis Therapeutics (LSE:SVNS) Cleared A Key Hurdle For Its Addiction Drug?
Highlights Bridging data showed drug levels comparable with an approved depression medicine. The results support plans for a larger mid-stage trial in alcohol use disorder. Solvonis acquired Awakn Life Sciences to build its pipeline. Data T…
Covered by 1 outlet
All coverage · 1 article